TENAX THERAPEUTICS, INC. — All Filings
925 total filings on record
Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.
All
10-K
10-K/A
10-K405
10-KT
10-Q
10-Q/A
10KSB
10QSB
3
4
4/A
424B1
424B3
424B4
424B5
5
8-A12B
8-K
8-K/A
ARS
CERTNAS
CORRESP
CT ORDER
D
DEF 14A
DEFA14A
EFFECT
FWP
NT 10-K
NT 10-Q
NTN 10K
POS AM
PRE 14A
PRER14A
REGDEX
REGDEX/A
RW
S-1
S-1/A
S-1MEF
S-2
S-3
S-3/A
S-8
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SCHEDULE 13D
SCHEDULE 13G
SCHEDULE 13G/A
SEC STAFF LETTER
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| 4 | PRIMARY DOCUMENT | 0001654954-25-007737 | Jul 3, 2025 | Jul 1, 2025 |
| 4 | PRIMARY DOCUMENT | 0001654954-25-007738 | Jul 3, 2025 | Jul 1, 2025 |
| SCHEDULE 13G | — | 0001104659-25-064157 | Jun 30, 2025 | — |
| 8-K | FORM 8-K | 0001654954-25-007104 | Jun 17, 2025 | Jun 11, 2025 |
| 4 | PRIMARY DOCUMENT | 0001654954-25-005949 | May 20, 2025 | May 16, 2025 |
| 4 | PRIMARY DOCUMENT | 0001654954-25-005950 | May 20, 2025 | May 16, 2025 |
| SCHEDULE 13G | — | 0000950170-25-072034 | May 15, 2025 | — |
| SCHEDULE 13G/A | — | 0001415889-25-013260 | May 15, 2025 | — |
| 10-Q | 10-Q | 0000950170-25-071395 | May 14, 2025 | Mar 31, 2025 |
| 8-K | 8-K | 0000950170-25-071382 | May 14, 2025 | — |
| SCHEDULE 13G/A | — | 0001274173-25-000175 | May 14, 2025 | — |
| DEF 14A | DEF 14A | 0000950170-25-058329 | Apr 25, 2025 | Apr 24, 2025 |
| DEFA14A | DEFA14A | 0000950170-25-058332 | Apr 25, 2025 | — |
| ARS | ARS | 0000950170-25-058333 | Apr 25, 2025 | Dec 31, 2024 |
| 424B3 | FORM 424B3 | 0001654954-25-004572 | Apr 23, 2025 | — |
| EFFECT | — | 9999999995-25-001213 | Apr 23, 2025 | — |
| CORRESP | — | 0001654954-25-004482 | Apr 21, 2025 | — |
| UPLOAD | — | 0000000000-25-004165 | Apr 18, 2025 | — |
| S-3 | S-3 | 0001654954-25-004312 | Apr 15, 2025 | — |
| PRE 14A | PRE 14A | 0000950170-25-052503 | Apr 9, 2025 | — |
| SCHEDULE 13G/A | — | 0001943462-25-000006 | Apr 4, 2025 | — |
| 10-K | 10-K | 0000950170-25-044398 | Mar 25, 2025 | Dec 31, 2024 |
| 8-K | 8-K | 0000950170-25-044375 | Mar 25, 2025 | — |
| SCHEDULE 13G/A | — | 0001079973-25-000408 | Mar 18, 2025 | — |
| 4 | PRIMARY DOCUMENT | 0001943462-25-000004 | Mar 12, 2025 | Mar 5, 2025 |
| 8-K | FORM 8-K | 0001654954-25-002385 | Mar 6, 2025 | Mar 4, 2025 |
| SCHEDULE 13G/A | — | 0001274173-25-000095 | Feb 14, 2025 | — |
| SCHEDULE 13G/A | — | 0001943462-25-000002 | Jan 15, 2025 | — |
| 3 | PRIMARY DOCUMENT | 0001943462-25-000001 | Jan 10, 2025 | Jan 8, 2025 |
| 4 | PRIMARY DOCUMENT | 0001654954-24-015477 | Dec 12, 2024 | Dec 10, 2024 |
| 4 | PRIMARY DOCUMENT | 0001654954-24-015473 | Dec 12, 2024 | Dec 10, 2024 |
| 4 | PRIMARY DOCUMENT | 0001654954-24-015471 | Dec 12, 2024 | Dec 10, 2024 |
| 4 | PRIMARY DOCUMENT | 0001654954-24-015472 | Dec 12, 2024 | Dec 10, 2024 |
| 4 | PRIMARY DOCUMENT | 0001654954-24-015474 | Dec 12, 2024 | Dec 10, 2024 |
| 4 | PRIMARY DOCUMENT | 0001654954-24-015475 | Dec 12, 2024 | Dec 10, 2024 |
| 4 | PRIMARY DOCUMENT | 0001654954-24-015476 | Dec 12, 2024 | Dec 10, 2024 |
| 3 | PRIMARY DOCUMENT | 0001654954-24-015251 | Dec 6, 2024 | Dec 2, 2024 |
| SCHEDULE 13G | — | 0001943462-24-000006 | Dec 5, 2024 | — |
| 8-K | FORM 8-K | 0001654954-24-015161 | Dec 4, 2024 | Dec 2, 2024 |
| S-8 | FORM S-8 | 0001654954-24-014917 | Nov 26, 2024 | — |
| SC 13G/A | JANUS AMENDMENT | 0001274173-24-000120 | Nov 14, 2024 | — |
| SC 13G/A | SC 13G/A | 0001104659-24-118640 | Nov 14, 2024 | — |
| SC 13G | — | 0000929638-24-003915 | Nov 14, 2024 | — |
| 10-Q | FORM 10-Q | 0001654954-24-014262 | Nov 13, 2024 | Sep 30, 2024 |
| SC 13G/A | — | 0000935836-24-000669 | Nov 13, 2024 | — |
| 8-K | FORM 8-K | 0001654954-24-014203 | Nov 13, 2024 | — |
| SC 13G | TENAX THERAPEUTICS, INC. | 0000902664-24-006402 | Nov 12, 2024 | — |
| 8-K | FORM 8-K | 0001654954-24-013505 | Oct 30, 2024 | Oct 25, 2024 |
| DEF 14A | DEF 14A | 0001654954-24-012375 | Sep 27, 2024 | Oct 25, 2024 |
| 424B3 | FORM 424B3 | 0001654954-24-011845 | Sep 12, 2024 | — |